Elizabeth A. Barrett Uro Gen Pharma Ltd. (URGN) insider trading activity
Elizabeth A. Barrett is Chief Executive Officer of UroGen Pharma Ltd.. Currently has a direct ownership of 326,691 shares of URGN, which is worth approximately $3.75 Million. The most recent transaction as insider was on Jan 31, 2023, when has been sold 18,333 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
327K
0%
3M change
0%
12M change
Total Value Held
$3.75 Million
Elizabeth A. Barrett Transaction History
Also insider at
EAB
Elizabeth A. Barrett
Chief Executive Officer
South San Francisco, CA